An Open Level Study to Assess the Glycemic Control Effect of Metformin and Pioglitazone as Add on Therapy Along With Sulfonylurea in Uncomplicated Type2 Diabetes Mellitus

Journal of Diabetes Mellitus
doi 10.4236/jdm.2012.22030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc.

Related search

The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-On Therapy to Metformin in Patients With Uncontrolled Type 2 Diabetes Mellitus

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

A Randomized, Open Label, Comparative Study of Biotin as an Add-On Therapy to Metformin vs Metformin Alone in Newly Diagnosed Type 2 Diabetes Mellitus Patients

IOSR Journal of Dental and Medical Sciences
2016English

The EFFECT OF SKT3 MEDITATION EXERCISE TO CONTROL HbA1c LEVEL OF TYPE2 DIABETES MELLITUS PATIENTS

International Journal of Public Health and Clinical Sciences
2018English

Permanent Neonatal Diabetes Mellitus: Same Mutation, Different Glycemic Control With Sulfonylurea Therapy on Long-Term Follow-Up

JCRPE Journal of Clinical Research in Pediatric Endocrinology
Child HealthEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2012English

Cost-Effectiveness Analysis of Linagliptin Versus Sulfonylurea as Add-On Treatment to Metformin for the Treatment of Diabetes Mellitus Type 2 Patients in Indonesia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Phase 3 Randomized Placebo-Controlled Trial to Assess the Efficacy and Safety of Ipragliflozin as an Add-On Therapy to Metformin in Russian Patients With Inadequately Controlled Type 2 Diabetes Mellitus

Diabetes Research and Clinical Practice
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2018English

Comparison of Antioxidative Effect of Metformin and Combination of Metformin-Sulfonylurea in Type 2 Diabetes Mellitus Patients

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2017English

Efficacy of Add – On Vildagliptin Therapy to Metformin for Type Ii Diabetes Mellitus Patients in South Indian Resource Limited Settings – Pilot Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Dapagliflozin: Cost-Effectiveness as an Add-On Therapy to Metformin in the Treatment of Type 2 Diabetes (T2DM) in Argentina and Chile

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy